2020
DOI: 10.1093/jscr/rjaa258
|View full text |Cite
|
Sign up to set email alerts
|

Single-session, dual-site robotic surgery for synchronous primary malignancies of the oropharynx and thorax

Abstract: Single-session, dual-site robotic surgery for synchronous malignancies is not widely reported. To our knowledge, there are no previous reports of transoral robotic surgery (TORS) and robot-assisted thoracic surgery (RATS) in a single sitting. A 49-year-old male presented with a neck lump. Biopsies and imaging proved synchronous primaries of the tonsil and lung. The morbidity of primary dual-site chemoradiotherapy, or open surgery, presented a management challenge. We therefore opted for sequential robotic rese… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…Over time, the team became more confident, such that, 16 months after our first case, we successfully performed our first dual-site robotic surgery jointly with thoracic surgeons. 28…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Over time, the team became more confident, such that, 16 months after our first case, we successfully performed our first dual-site robotic surgery jointly with thoracic surgeons. 28…”
Section: Discussionmentioning
confidence: 99%
“…Over time, the team became more confident, such that, 16 months after our first case, we successfully performed our first dual-site robotic surgery jointly with thoracic surgeons. 28 In 24 of the 33 transoral robotic surgery diagnostic procedures performed, the primary tumour site was identified. This had a major impact on management, as these patients were all enrolled in the PATHOS trial, and potentially could avoid chemotherapy or chemo-radiotherapy.…”
Section: Discussionmentioning
confidence: 99%